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Genetic Defects in TAPT1 Disrupt Ciliogenesis
and Cause a Complex Lethal Osteochondrodysplasia
Sofie Symoens,1,8 Aileen M. Barnes,2,8 Charlotte Gistelinck,1,8 Fransiska Malfait,1 Brecht Guillemyn,1
Wouter Steyaert,1 Delfien Syx,1 Sanne D’hondt,1 Martine Biervliet,3 Julie De Backer,1
Eckhard P. Witten,4 Sergey Leikin,5 Elena Makareeva,5 Gabriele Gillessen-Kaesbach,6 Ann Huysseune,4
Kris Vleminckx,1,7 Andy Willaert,1 Anne De Paepe,1 Joan C. Marini,2 and Paul J. Coucke1,*
The evolutionarily conserved transmembrane anterior posterior transformation 1 protein, encoded by TAPT1, is involved in murine
axial skeletal patterning, but its cellular function remains unknown. Our study demonstrates that TAPT1mutations underlie a complex
congenital syndrome, showing clinical overlap between lethal skeletal dysplasias and ciliopathies. This syndrome is characterized by
fetal lethality, severe hypomineralization of the entire skeleton and intra-uterine fractures, and multiple congenital developmental
anomalies affecting the brain, lungs, and kidneys. We establish that wild-type TAPT1 localizes to the centrosome and/or ciliary basal
body, whereas defective TAPT1mislocalizes to the cytoplasm and disrupts Golgi morphology and trafficking and normal primary cilium
formation. Knockdown of tapt1b in zebrafish induces severe craniofacial cartilage malformations and delayed ossification, which is
shown to be associated with aberrant differentiation of cranial neural crest cells.Introduction
The primary cilium is a highly specialized organelle that
projects from the cell surface, senses extracellular signals
through various receptors on the ciliary membrane, and
transduces these signals to the nucleus.1 It is crucial for pro-
liferation and differentiation ofmany cell types and for em-
bryonic andpostnatal development ofmultiple organs. The
importance of the primary cilium is further illustrated by
the occurrence of a heterogeneous group of heritablemulti-
systemic disorders, collectively called the ciliopathies, that
are linked to defective ciliogenesis and are caused by a
multitude of genes that affect ciliary structure and/or func-
tion.2 Clinical phenotypes include, among others, retinal
degeneration, polycystic kidneys, cerebral anomalies, infer-
tility, diabetes, and obesity.1,2 Recent research in mice has
also revealed themedical relevance of primary cilia to verte-
brate skeletal development, as illustrated by their impor-
tance in, among others, mesenchymal stem cell, chondro-
cyte, and osteoblast differentiation.1
This study describes two consanguineous families in
which several pregnancies were terminated due to the pres-
ence of multiple bone fractures and deformities, undermi-
neralization of the skull and axial skeleton, and congenital
anomalies, including ascites, pleural effusion, and intracra-
nialventriculomegaly (Figures1A–1FandFigureS1).Because
of the presence of multiple intra-uterine fractures, the diag-
nosis of lethal osteogenesis imperfecta (OI [MIM: 166210])
was suspected at referral.3 Molecular analysis of the type I
procollagen-encoding genes4 and more recently described
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The AmericCombined whole-genome homozygosity mapping and
exome sequencing for the first family (family 1) and direct
Sanger sequencing for a second family (family 2) led to the
identification of pathogenic homozygous mutations in
TAPT1, encoding the evolutionary highly conserved trans-
membrane anterior posterior transformation 1 protein.
Immunocytochemical staining experiments demonstrated
that the fetal fibroblasts from both families have defective
cilium formation and organization of the Golgi apparatus,
including delayed intracellular protein trafficking. Knock-
down of zebrafish tapt1b resulted in severe malformations
of the craniofacial skeleton and delayed ossification, for
which tapt1b was shown to be linked to disturbed differen-
tiation of cranial neural crest (CNC) cells.Material and Methods
Family Ascertainment
Family 1 (F1; Figure 1A) is a consanguineous Moroccan family
with three affected fetuses (II-3, II-7, and II-8) born after interrup-
tion of pregnancy (IOP) due to multiple fractures and severe bone
deformities. Family 2 (F2; Figure 1B) is a Syrian consanguineous
family with three affected fetuses (IV-3, IV-4, and IV-6); two
affected fetuses were delivered after IOP and the third affected
sibling was part of a non-identical dichorial-diamniotic twin preg-
nancy. The major clinical features in both families included gener-
alized severe skeletal osteopenia, microcephaly, multiple fractures,
and congenital anomalies, including ascites, pleural effusion, and
intracranial ventriculomegaly.
Skin biopsies were obtained from the affected fetuses of both
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Figure 1. Pedigrees of Affected Families
and Clinical Description
(A–B) Pedigrees of family 1 (F1) and family
2 (F2). Black symbols, affected individuals
carrying a homozygous TAPT1 mutation;
strikethrough symbols, deceased individ-
uals.
(C–D) Radiographs of fetus II-7 from
family 1. Frontal (C) and lateral (D) views
show generalized osteopenia of the skull,
a barrel-shaped thorax with short ribs,
andmultiple posterior and axillary rib frac-
tures. Upper and lower extremities are
undermineralized.
(E–F) Radiographs of fetus IV-3 from family
2. Frontal (E) and lateral (F) views how
generalized radiolucency of the entire skel-
eton, thin ribs with multiple fractures, and
fractures of upper and lower extremities.were collected from the unaffected siblings of family 1 and of the
unaffected parents of family 2. No bone specimens of the affected
fetuses of either family were available.
Because of the generalized radiolucency of the skeleton and the
presence of multiple fractures, a clinical diagnosis of lethal OI was
suspected. Molecular analysis of the type I procollagen-encoding
genes (COL1A1 [MIM: 120150] and COL1A2 [MIM: 120160]),5 as
well as other genes, in which mutations are associated with
severe-to-lethal OI (LEPRE1 [MIM: 610339],6–8 CRTAP [MIM:
605497],8,9 PPIB [MIM: 123841],10,11 BMP1 [MIM: 112264],12,13
SERPINH1 [MIM: 600943],14,15 SERPINF1 [MIM: 172860],16 and
CREB3L1 [MIM: 616215]17), did not reveal a causal mutation in
either family. To completely excludemutations inOI-related genes,
molecular analysis of all other genes known to be linked to
OI (FKBP10 [MIM: 607063],18 SP7 [MIM: 606633],19 PLOD2
[MIM: 601865],20 IFITM5 [MIM: 614757],21,22 WNT1 [MIM:
164820],23–25 TMEM38B [MIM: 611236], 26,27 and the PLS3 [MIM
300131] 28 gene involved in X-linked osteoporosis) was performed,
but no causal mutations could be detected.Study Approval
The study was approved by the ethics committee of the Ghent
University Hospital, the National Institute of Child Health and
Human Development institutional review board, and Universita¨t
zu Lu¨beck Schleswig-Holstein. Informed consent was obtained
from both families.Molecular Studies
Whole-Genome Homozygosity Linkage Mapping and Whole-Exome
Sequencing for Family 1
Genome-wide homozygosity linkagemapping in family 1 was per-
formed (ABI 400marker set) for the three affected fetuses (II-3, II-7,
and II-8) of family 1 after pooling of their DNA prior to linkage522 The American Journal of Human Genetics 97, 521–534, October 1, 2015analysis. Homozygous regions were
confirmed at the gDNA level separately
for each fetus, and segregation analysis of
the homozygous SNP markers was per-
formed for each family member. Subse-
quently, exome sequencing on gDNA
from fetus II-3 from family 1 was per-
formed by Aros Applied BiotechnologyAS. The TruSeq Exome Enrichment Kit (Illumina) was used for
exome capture, and sequencing was carried out on the Illumina
HiSeq 2000 platform with paired-end 100-bp reads. The CLC
Genomics Workbench v.5.1 (CLCBio) software was used for dupli-
cate-read removal, readmapping against the human genome refer-
ence sequence (NCBI Genome browser GRCh37.p5), coverage
analysis, and variant calling. Variant annotation was performed
with the Genomics Gateway beta plug-in (CLCBio). Resulting
variants were comparedwith 27 in-house exomes from individuals
with unrelated genetic disorders. Non-synonymous variants,
variants located at acceptor and donor splice sites, and small
coding insertions or deletions with at least 10-fold coverage, a rela-
tive allele frequency of at least 90% (in order to detect homozy-
gous sequence changes), and that were not present in the Single
Nucleotide Polymorphism database (dbSNP135) were further
considered. In addition, genes previously linked with ciliary
chondrodysplasias were analyzed (filter settings were as follows:
all coding exons including 20 base pairs from flanking introns,
coverage R 3, forward and reverse read counts R 1, and popula-
tion frequency < 10%; Tables S3 and S4). No causal mutations
were identified.
TAPT1 [MIM: 612758] was sequenced at the gDNA level by
direct Sanger sequencing (ABI3730XL automated sequencer,
Applied Biosystems). The segregation of the TAPT1 mutation
was investigated in all family members of family 1. PCR amplifi-
cation and direct Sanger sequencing of all exons and flanking in-
trons of the entire TAPT1 gene were performed for family 2
(primer sequences available upon request). Mutation nomencla-
ture is in accordance to the Human Genome Variation Society
guidelines (TAPT1 reference sequence [GenBank: NM_153365.2]).
The mutation was analyzed with the Alamut Visual 2.5 software
(includes prediction algorithms SIFT, MutationTaster, and Poly-
Phen-2), Splice Site Prediction by Neural Network,29 and Human
Splicing Finder30 software, and its absence was checked in 105
control samples31 and in the 1000 Genomes database. RT-PCR
was performed on total mRNA to determine the splicing
outcome. Multiple sequence alignment of the TAPT1 protein
sequence was consulted at the NCBI website (HomoloGene). In
silico analysis of the TAPT1 protein sequence was performed
with the algorithms TopPred II, TMpred, Phobius, and PSORT II
(Expasy).In Vitro Studies
Generation of TAPT1 Expression Constructs
Using total fibroblast RNA of two fetuses from families 1 (fetus II-7)
and 2 (fetus IV-4), as well as of control cells, the entire coding
sequence of TAPT1 was amplified by PCR. Primer sequences
were complemented with additional sequences specific for the re-
striction enzymes HindIII and XhoI at their 50 end in order to
allow for unidirectional cloning into the pcDNA3 eukaryotic
expression vector (50-AAGCTTCCAGTTTGTTGTGCTCGGAAC-30
TAPT1_F_HindIII and 50-CTCGAGGAAGCCACACAGATTCAG
TCAAT-30 TAPT1_R_XhoI). After PCR amplification, amplicons
were cloned into the pCR2Topo vector (Invitrogen), digested
with the restriction enzymes HindIII and XhoI, and ligated into
the pcDNA3 eukaryotic expression vector (Life Technologies).
Sequences were checked by bidirectional Sanger sequencing
(ABI3730XL automated sequencer, Applied Biosystems).
Immunoprecipitation of TAPT1
In order to investigate the production and secretion of the wild-
type and defective TAPT1 proteins, dermal control fibroblasts,
and dermal fibroblasts of fetus II-3 from family 1 and fetus IV-6
from family 2 were lysed with RIPA buffer (Sigma). Cell lysates
were incubated with Dynabeads Protein A, to which TAPT1 pri-
mary antibody (HPA042567, Sigma) was bound. Subsequently,
bound proteins were eluted and subjected to western blot analysis.
siRNA and shRNA Experiment
For the siRNA experiment, the efficiency of transfection and
knockdown was determined according to the manufacturer’s pro-
tocol (Thermo Scientific DharmaFECT transfection reagents,
siRNA Transfection Protocol) in an initial pilot study. In brief,
30,000 MG-63 cells were seeded per well in an eight-well chamber
slide format with varying DharmaFECT 1 siRNA Transfection
Reagents (Thermo Fisher Scientific Biosciences, T-2001-01) and
varying ON-TARGETplus human TAPT1 siRNA - SMARTpool
(Thermo Fisher Scientific Biosciences, L-015826-02-0005) or ON-
TARGETplus siCONTROL Non-Targeting Pool (Thermo Fisher
Scientific Biosciences, D-001810-10-05). On the basis of this pilot
study, the 1/666 dilution for DharmaFECT 1 siRNA Transfection
Reagent and the 50 nM siRNA pool were selected because they
generated the best TAPT1 knockdown percentage (determined
by qPCR: 77.38% TAPT1 knockdown when comparing TAPT1
siRNA treated cells to negative control cells).
Subsequently, bone osteosarcoma cells (MG-63 cells) were
seeded and grown in 8-chamber glass slides (30,000 cells/well)
for immunocytochemistry and RNA isolation. 24 hr post-seeding,
cells were transfected with 50 nMON-TARGETplus Human TAPT1
siRNA - SMART pool (Thermo Fisher Scientific Biosciences,
L-015826-02-0005) or 50 nM ON-TARGETplus siCONTROL Non-
Targeting Pool (Thermo Fisher Scientific Biosciences, D-001810-
10-05) and DharmaFECT 1 siRNA Transfection Reagent (1/666
dilution, Thermo Fisher Scientific Biosciences, T-2001-01). 24 hr
post-transfection cells were starved for 24 hr and harvested. The ef-
ficiency of TAPT1 knockdown was determined by qPCR (knock-
down of TAPT1 expression: 72%).The AmericIn order to get stable shRNA MG-63 cell lines, a virus for
TAPT1 (Sigma, TRCN0000136711, TRCN0000136644, and
TRCN0000134168), a positive control LMNA (Sigma,
TRCN0000061835), and a negative control (Sigma, SHC002) were
generated with Trans-Lentiviral Packaging Mix (Thermo,
catTLP4606). Subsequently, 250,000 MG-63 cells were seeded in a
six-well format, transduced in a 1/8 ratio, and selected with 2 mg/ml
puromycin (Sigma, 250 mg of P7255). Finally, knockdown percent-
age was determined by qPCR (calculated in comparison to the nega-
tive control): 32.12% TAPT1 knockdown for TRCN0000136711,
–5.70% TAPT1 knockdown for TRCN0000136644, 29.40% TAPT1
knockdown for TRCN0000134168, and 84.45% LMNA knock-
down for TRCN0000061835. For TRCN0000136711, an immunocy-
tochemical stainingexperiment, inwhichcellswerestarvedfor48hr,
was performed for TAPT1 and acetylated tubulin. To quantify the
staining for TAPT1, the size of the centrosomes was measured
(blindly, by two independent investigators; 150 centrosomes were
measured per sample).
Immunocytochemistry
Transfected HEK293T cells, TAPT1 siRNA-treated MG-63 cells, and
dermal fibroblasts from fetus II-3 from family 1, fetuses IV-4 and
IV-6 from family 2, and a control individual were grown on glass
chamber slides and at confluency, starved for 24hr. Cells were fixed
with3.7%paraformaldehyde,blocked in10%BSA inPBS, and incu-
batedwith primary antibodies against TAPT1 (Sigma,HPA042567),
a-acetylated tubulin (Sigma, T6793), Golph4 (Abcam, ab280489),
and g-tubulin (Abcam, ab11316). After washing, cells were incu-
bated with secondary antibodies (goat anti-mouse Alexa Fluor
488 and donkey anti-rabbit Alexa Fluor 594) and mounted with
coverslips. Images were capturedwith a Zeiss AxioObserved-Z1mi-
croscope. Cilium formation was independently evaluated by three
investigators by counting the number of cells that formed a cilium
and by assessing cilium abnormalities.
Centrosome Purification, Sucrose Gradient Ultracentrifugation, and
Western Blotting
Centrosome preparation was performed as previously described.32
Ten million exponentially growing HEK293T or MG-63 cells were
incubated with culture medium containing 1 mg/ml cytochalasin
D and 0.2 mM nocodazole for 1 hr at 37C to depolymerize actin
and microtubule filaments. Cells were harvested by trypsinization
and lysed in 5 ml solution of 1 mMHEPES (pH 7.2), 0.5% Nonidet
P-40, 0.5mMMgCl2, and 0.1% 2-mercaptoethanol with EDTA-free
proteinase inhibitors. Swollen nuclei and chromatin aggregates
were removed by centrifugation at 2,500 3 g for 10 min, and
the supernatant was filtered through a 40-mm nylon mesh. HEPES
was adjusted to 10 mM, DNase I was added to 2 U/ml, and the
mixture was incubated for 30 min on ice. The lysate was underlaid
with 500 ml 60% sucrose solution (60% wt/wt sucrose in 10 mM
Pipes, pH 7.2 in 0.1% Triton X-100 in 0.1% 2-mercaptoethanol)
and centrosomes were sedimented into the sucrose cushion by
centrifugation at 10,0003 g for 30min. 1.5 ml of the bottom layer
was pipetted onto a discontinuous sucrose gradient (500 ml of
70%, 300 ml of 50%, and 300 ml of 40% sucrose solutions) and
centrifuged at 120,000 3 g for 1 hr. Fractions were collected
from the top: 1,200 ml for the first fraction and 200 ml for fractions
two–eight. Each fraction was diluted in 1 ml of 10 mM Pipes
buffer, pH 7.2. Centrosomes were recovered by centrifugation at
13,200 rpm for 15 min and dissolved in 100 ml 23 Laemmli buffer.
Samples were reduced and proteins were separated on NU-PAGE
4%–12% Bis-Tris gels, transferred to nitrocellulose membranes,
blocked for 1 hr with 2% blocking agent in 13 tris-buffered saline
with Tween-20 (TBST), and developed with primary antibodiesan Journal of Human Genetics 97, 521–534, October 1, 2015 523
anti-TAPT1 (Sigma, HPA042567, 1/1,000) or anti-g-tubulin (Ab-
cam, ab11316, 1/1,000) and secondary antibodies anti-rabbit
horseradish peroxidase (HRP) linked (Bioke´, 7074S, 1/1,500) or
anti-mouse HRP linked (Bioke´, 7076S, 1/1,500).
Steady-State Collagen Analysis
Control cells and fibroblasts from affected members from family 1
and family 2 were grown to confluence in six-well culture dishes.
Steady-state collagen analysis was conducted as previously
described.33 In brief, fibroblasts were labeled overnight with
[3H]-proline. Medium and cell layer collagens were ammonium
sulfate precipitated and pepsin-digested before electrophoresis
on a 6% SDS-urea-PAGE.
Folding Assay of Type I Collagen
Collagen folding assays were performed as previously described.34
In brief, confluent fibroblasts were pulsed with [14C]-proline for
15 min and cell layer procollagens were collected every 5 min.
Samples were digested with trypsin and chymotrypsin for 2 min
and halted with soybean trypsin inhibitor. Collagens were precip-
itated with 4 M NaCl in 1 M acetic acid overnight, washed in 70%
EtOH, and electrophoresed on a 3%–8% tris-acetate gel (Life Tech-
nologies). Densitometry of the a1(I)-chains was measured with
ImageJ software and normalized to control measurements.
Pulse-Chase Secretion Kinetics
As described previously,35 confluent fibroblasts were labeled for
4 hr with [14C]-proline and chased with fresh medium containing
2 mM cold proline. Medium and cell layer procollagens were har-
vested at the indicated times and pepsin-digested. Two wells for
each assay were left unlabeled to provide an accurate cell count
for normalization between cell lines. Normalized samples were
run on a 3%–8% tris-acetate gel (Life Technologies), and a1(I)-
collagen bands were measured by densitometry with ImageJ for
calculation of the percent secretion.
Amino Acid Analysis
Amino acid analysis to quantify hydroxylysine and lysine was per-
formed by high-pressure liquid chromatography (AIBiotech).9
Differential Scanning Calorimetry and Differential Scanning Circular
Dichroism
Differential scanning calorimetry and differential scanning circular
dichroism of collagen solutions in 0.2 M sodium phosphate and
0.5 M glycerol at pH 7.4 were performed as previously described.36
Trafficking Assay and Immunofluorescence Microscopy
Control and fetal (fetus II-3 from family 1 and fetus IV-4 from family
2) fibroblasts were plated on two-well chamber slides. Cells were
washed and incubated on ice with cholera toxin subunit B
(CTx-B)-488 (LifeTechnologies) for 15 min, then incubated for 1 hr
at 37C in serum-free media before fixing in 4% paraformalde-
hyde.37 Cells were permeabilized in 1% serum plus 0.2% Triton
X-100, washed, and blocked in 1%BSA in PBS. Cells were incubated
withGolgin-97 (Life Technologies),washed, incubatedwith second-
aryantibody, andstainedwithDAPI (VectorLabs).Cellswere imaged
on a Zeiss LSM510 confocalmicroscope, with the supplied software.Zebrafish Studies
Zebrafish Maintenance
Wild-type AB and transgenic Tg(Fli1:EGFP) and Tg(Col2:mcherry)
zebrafish were reared at a constant temperature of~28C and
maintained by standard protocols. Transgenic lines were reported
previously.38,39
In Situ Hybridization
High-resolution whole-mount in situ hybridization (WISH) of ze-
brafish embryos was carried out as previously described.40 Dioxy-524 The American Journal of Human Genetics 97, 521–534, Octobergenin uridine-50-triphosphate (DIG)-labeled RNA probes (se-
quences available upon request) targeting the zebrafish tapt1b,
barx1,41 and sox9a42 genes were used to study expression at 24,
48, 60, 72, and 96 hr post fertilization (hpf). Whole-mount em-
bryos were observed and photographed with a Leica M165 FC
Fluorescent Stereo Microscope (Leica Microsystems). Hybridized
specimens were processed for embedding in epon and serial cross
sectioning (4 mm).43 Photomicrographs were taken with a Zeiss
Axioimager Z1 equipped with differential interference contrast
(DIC) optics and an Axiocam MRc camera. Morphants (96 hpf)
were compared to 72 hpf uninjected zebrafish to account for a
possible developmental delay.
Morpholino Injections
Antisense splice-blocking morpholinos (MOs; Gene Tools) were
designed against the intron-1-exon-2 (i1e2) acceptor splice site
(50-GAGATCTGCACACAGACATACAAAT-30) and the exon-2-
intron-2 (e2i2) donor splice site (50-AGCTGTGTTTGGTACTGT
ACCTTCT-30) of tapt1b. Routinely, MOs were microinjected in
1–5 nl of volume into one- to two-cell stage wild-type embryos
at 2 ng for both tapt1b i1e2 MOs and tapt1b e2i2 MOs. To control
for possible non-specificity effects of MO injection, (1) MO injec-
tions were performed in parallel with a standard control MO, and
(2) MOs were injected in p53 mutant zebrafish embryos to check
for p53-induced apoptosis.44 All MOs were dissolved in 0.5%
phenol red and 13 Danieu’s buffer [58 mM NaCl, 0.7 mM KCl,
0.4 mM MgSO4, 0.6 mM Ca(NO3)2, 5.0 mM HEPES (pH 7.6)].
MO-injected specimens were processed in epon followed by serial
cross sectioning (1 mm and staining with toluidine blue [0.5% in
1% borax]). Photomicrographs were taken with a Zeiss Axioimager
Z1 and an AxiocamMRc camera.
CRISPR/Cas Injections
Tapt1b CRISPR target sequences (available on request) were identi-
fied with CRISPRdirect. Cas9-NLS protein (250 pg; LabOmics) and
gRNA (25 pg) were co-injected into one-cell-stage wild-type
embryos.
Alcian Blue Staining
Cartilage was stained with Alcian blue, via a modified protocol of
Neuhauss et al., 1996.45 Uninjected, tapt1b MO- and tapt1b
CRISPR/Cas (F0 tapt1bCas9/gRNA)-injected larvae were collected at
4 days post fertilization (dpf) and fixed overnight in 4% parafor-
maldehyde and washed several times in PBS with 0.1% Tween-
20 (PBST). In order to enhance their optical clarity, the specimens
were bleached in a solution containing 1.5% hydrogen peroxide
and 1% potassium hydroxide for 2 hr or until the embryos were
sufficiently translucent. The embryos were rinsed in PBST and
transferred into an Alcian blue solution (1% concentrated hydro-
chloric acid, 70% ethanol, 0.1% Alcian blue) and stained over-
night. Specimens were cleared in acidic ethanol (5% concentrated
hydrochloric acid, 70% ethanol) for 4 hr and rehydrated in an
ethanol series. To further reduce background staining and interfer-
ence of surrounding tissues, a digest was done with a 1 mg/ml
Trypsine solution in 60% saturated borax for 20 min. Finally, the
specimens were rinsed with demineralized water and gradually
transferred to pure glycerol for documentation and storage.
Analysis was done using a Leica M165 FC Fluorescent Stereo
Microscope.
Alizarin Red Staining
Fixed specimens were stained via a modified protocol.46 Embryos
were fixed in 4% paraformaldehyde in 0.1 M sodium phosphate
buffer for 1 hr, washed with demineralized water, and subse-
quently bleached in 1% hydrogen peroxide in 1% potassium hy-
droxide for 30 min. After bleaching, embryos were stained with1, 2015
0.5% Alizarin Red S (Sigma) in a 1% potassium hydroxide in 2%
Triton X-100 solution. Clearing was carried out in a solution con-
taining 20% glycerol and 0.25% potassium hydroxide. Specimens
were stored at 4C in 100% glycerol.
Whole-Mount Immunofluorescence
Immunofluorescence staining was performed as previously
described.47 Embryos were digested in 10 mg/ml proteinase K for
5 min at room temperature after fixation in 4% paraformaldehyde
in PBS. The embryos were subsequently washed in PBS þ 0.8%
TritonX-100 and blocked in 10%normal goat serum: 1%dimethyl
sulphoxide in PBS þ 0.8% Triton X-100 blocking solution for 1 hr
at room temperature. This was followed by incubation with pri-
mary antibody at 4C overnight (anti-acetylated mouse alpha-
tubulin, 1:1,000, Sigma, T6793) in blocking solution. Following
several washes, the embryos were incubated at 4C overnight in
an appropriate fluorescent secondary antibody (goat anti-rabbit
Alexa Fluor 488, 1:200, Invitrogen, A10034). Fluorescently labeled
embryos were imaged on a Leica TCS LSI Super Zoom confocal mi-
croscope (Leica Microsystems). Cilial length in the otic vesicle of
three morphants and three uninjected controls was measured on
maximal intensity projections with the Leica Application Suite
Advanced Fluorescence software (Leica Microsystems).
Statistics
Statistical analysis for the measurements of the cilial length in the
otic vesicle of the zebrafish was carried out with R software.
Continuous outcome variables exhibiting a skewed distribution
were transformed, using the natural logarithms, before a two-
way ANOVAwas conducted to satisfy the prerequisite assumptions
of normality. To assess the difference in cilia length between the
morphants and the control group, the non-parametric Mann-
Whitney U test was performed in non-transformed data.Results
Clinical Phenotype
Family 1
Family 1 (Figure 1A) is a consanguineous family of Moroc-
can origin with three affected fetuses (individuals II-3, II-7,
and II-8) delivered after IOP due to multiple fractures and
severe bone deformities. Both parents are healthy, have
no signs of increased bone fragility, and have six living
healthy children.
The first fetus (II-3; Figures S1A–S1D) was a female (kar-
yotype 46, XX) who, at antenatal ultrasound examination
at 26 weeks of gestation, revealed multiple fractures, hy-
dramnios with ascites, and dilated third and fourth cere-
bral ventricles. Post-mortem examination showed a fetus,
small for gestational age, with a prominent forehead, hy-
pertelorism, short nose, broad nasal bridge, anteverted
nostrils, low-set ears, and a short and broad neck. Some
bony fragments were palpable over the skull. In addition,
short limbs with flexion contractures were noticed and
lower extremities were in abduction. Radiologic examina-
tion showed generalized radiolucency of the skeleton and
an incompletely ossified skull with wormian bones. The
thorax was small and thin with discontinuously beaded
ribs and platyspondyly of the vertebrae. The upper limbs
showed fractures of the humerus and metaphyseal flaring,
and the femora were very short, poorly modeled, and an-The Americgulated. The tibiae were relatively thin and bowed with
some metaphyseal flaring. The fibulae were extremely
thin and deformed.
The second fetus (II-7; Figures 1C and 1D) was delivered
at 18.5 weeks of gestation after IOP because ultrasono-
graphic examination revealed undermineralization of
the skull, short ribs, a barrel-shaped thorax, and bilateral
femur fractures. Post-mortem radiological examination
confirmed the presence of a barrel-shaped thorax with
multiple rib fractures, bilateral femur shaft fractures, frac-
tures of the radius and ulna, and fracture of the right tibia
shaft with mild bowing of the tibia. Also, decreased miner-
alization of the upper and lower extremities was noticed.
The third fetus (II-8) died in utero at 16 weeks of gesta-
tion. Post-mortem radiographs showed almost absent ossi-
fication of the skull, poor mineralization of the ribs with
multiple rib fractures, and fractures of the left and right
femur and right tibia shafts.
Family 2
Family 2 (Figure 1B) is a complex Syrian consanguineous
family with two affected fetuses (individuals IV-3 and
IV-4) who were delivered after IOP. A previous pregnancy
was terminated due to extrauterine gravidity. The third
affected sibling was part of a non-identical dichorial-dia-
mniotic twin pregnancy (individual IV-6). The parents
are healthy and have no signs of increased bone fragility
or any other congenital anomaly.
The first fetus (IV-3; Figures 1E and 1F) was a male
(karyotype 46, XY) in whom ultrasound examination at
19 weeks of gestation revealed brachycephaly of the skull
(occipital frontal circumference [OFC] was 144 mm), a
high prominent forehead, ventriculomegaly of the brain,
and a hypoplastic cerebellum. He had a flat face, microgna-
thia, and a hypoplastic nose. Skeletal investigation showed
the presence of multiple fractures of the ribs and long
bones and generalized radioluceny of the entire skeleton.
Other developmental anomalies included cardiomegaly,
ascites, hygroma colli, a small thorax, and a single umbili-
cal artery.
The second fetus (IV-4; Figures S1E and S1F) was a female
(karyotype 46, XX) who also showed intra-uterine growth
retardation (weight of the fetus was 190 g, whereas compa-
rable gestational fetuses weigh ~359 g). Ultrasound exam-
ination at 19 weeks of gestation revealed a fetus with mi-
crobrachycephaly of the skull (OFC was 12.2 cm, 12.8
SD), a flat cerebellum, micrognathia, and a hypoplastic
nose. In addition, multiple fractures of the ribs and long
bones and generalized osteopenia of the entire skeleton
were noticed. Other developmental anomalies included
cardiomegaly, pleural effusion with mild ascites, hydrops
fetalis, lung hypoplasia, and a single umbilical artery.
The third affected sibling (IV-6; Figures S1G–S1K) is a
male sibling who was part of a dichorial-diamniotic twin
pregnancy. Whereas the female fetus developed normally,
the male fetus showed intrauterine growth retardation at
17 and 20 weeks of gestation. Moreover, brachymicroce-
phaly of the skull and agenesis of the brain vermis wasan Journal of Human Genetics 97, 521–534, October 1, 2015 525
Figure 2. Molecular Studies
(A) Electropherogram of TAPT1mutations.
The left two panels delineate the acceptor-
splice-site mutation c.1108-1G>C in F1;
the right two panels delineate the
missense mutation c.1058A>T in F2. For
each mutation, one affected fetus and
one unaffected carrier parent is shown.
(B) Multiple sequence alignment across
species of the TAPT1 mutated region re-
veals that the deleted and substituted
amino acids are highly conserved. The or-
ange text represents the highly conserved
exon 10. The amino acid residue in red
is the affected amino acid residue in
family 2.
(C) Immunoprecipitation of TAPT1 in
multiple cell types revealed that the pro-
tein migrates around 60 kDa. For the
sample of fetus II-3 from family 1 a
smaller molecular weight is observed,
which is in line with the production of
a shorter TAPT1 protein as a result of
the removal of exon 10 (deletion of 20
highly conserved amino acids and shorter
protein band marked with a red arrow).
As a positive control, cell lysates of
HEK293T cells, which were transfected
with the wild-type TAPT1 expression
construct, were loaded. Black arrow,
TAPT1 protein; asterisks, heavy chain of
the antibody used for immunoprecipitation; double asterisks, aspecific band; rTAPT, recombinant TAPT1; FB, fibroblasts; OB, osteo-
blasts; Fr1, fraction 1 ¼ cell lysate before immunoprecipitation; Fr3, fraction 3 ¼ eluate.noticed. He wasmicrocephalic and he had a unilateral cleft
lip and palate. Additionally, multiple fractures of the ribs
and the long bones and generalized undermineralization
of the entire skeleton were noticed. Other observed anom-
alies included a cardiac ventricular septal defect, hypertro-
phic cardiomyopathy and bilateral hydronephrosis, and
a single umbilical artery. Ultrasound investigation at
31 weeks of gestation revealed severe microcephaly (OFC
was 14.4 cm,8.4 SD). In addition, the skull was brachyce-
phalic. Fetus IV-6 also showed a high prominent forehead,
intracranial ventriculomegaly, and a hypoplastic cere-
bellum. Birth took place after 37 weeks of gestation. The
affected sibling had a birth weight of 1,140 g (–4.4 SD),
length of 43 cm (–3 SD), and OFC of 21 cm (–14 SD). Clin-
ical examination after birth revealed the following findings
in addition to the anomalies seen by ultrasound examina-
tion: large and fleshy posteriorly rotated ears, hypertelor-
ism, telecanthus, adducted thumbs, a micropenis, and
hypospadias.
Molecular Studies
Defects in TAPT1 Are the Underlying Genetic Cause
We used both genome-wide linkage analysis and whole-
exome sequencing to find the underlying genetic defect
for family 1 (individual II-3). A common homozygous re-
gion was identified on chromosome 4 (Figure S2, Table
S1) and contained two variants: a missense variant,
c.688C>T (p.His230Tyr), in the pseudogene FAM90A26P
(GenBank: XM_002342428.2) and an acceptor-splice-site526 The American Journal of Human Genetics 97, 521–534, Octobervariant, c.1108-1G>C in TAPT1 (GenBank: NM_153365.
2), which segregated with the phenotype (Figure 2A). We
considered the predicted transmembrane protein TAPT1
to be the better candidate given that TAPT1 is involved
in murine skeletal patterning.48,49 At the mRNA level,
the c.1108-1G>C splice-site variant resulted in skipping
of the highly conserved exon 10 (p.Val370_Asn389del,
Figure 2B, Figure S3A) and the production of a truncated
TAPT1 protein (Figure 2C).
Direct Sanger sequencing of TAPT1 in 58 probands with
a clinical diagnosis of severe-to-lethal congenital OI identi-
fied a homozygous missense variant (c.1058A>T,
p.Asp353Val), which is predicted by the Alamut Visual
software to be damaging and disease causing, in a second
family (F2, Figure 2A-C). Although little is known about
TAPT1 protein topology, both mutations are considered
to affect the second extracellular/luminal loop of this
transmembrane protein (Figures S3B and S3C).
Functional Studies
TAPT1 Is Localized at the Centrosome and/or Ciliary Basal Body
Region
We determined the subcellular localization of TAPT1.
Immunocytochemical staining showed that, in human fi-
broblasts, TAPT1 is present as an intense perinuclear
spot, which co-localizes with the centrosomal protein
g-tubulin (Figure 3A). The centrosomal localization of
TAPT1 in HEK293T and MG-63 cells was confirmed by
centrosome isolation and western blotting (Figure S5).1, 2015
Figure 3. TAPT1 Localizes to the Centro-
some and/or Base of the Cilium and Is
Important for Correct Ciliogenesis
(A) Immunostaining for TAPT1 (red), the
centrosomal protein g-tubulin (green),
and nuclei (DAPI, blue) in control fibro-
blasts revealed co-localization of TAPT1
and g-tubulin, implicating a centrosomal
localization of TAPT1.
(B) Immunostaining of control and pro-
band (II-3 from family 1 and IV-4 from
family 2) dermal fibroblasts for TAPT1
(red), primary cilium (acetylated a-tubulin,
green), and nuclei (DAPI, blue) showed
that control fibroblasts were capable of
inducing cilium formation after serum-
starvation, whereas proband-derived fibro-
blasts were severely deficient for normal
ciliogenesis. Fetus II-3 from family 1 failed
to organize acetylated a-tubulin into a
ciliary structure; instead, acetylated
a-tubulin was present throughout the
entire cell. On cells from fetus IV-4 from
family 2, cilia were short and broadened.
Additionally, multiple spots for TAPT1
were detected, implying that TAPT1 is mis-
localized within the entire cell. For panels
(A) and (B), close-ups are shown of the co-
lor-merged pictures: colored boundaries
(blue, orange-red, and yellow borders)
around the pictures denote the area
selected from the original pictures (see
Figure S4).Because centrosomal components play a role in ciliogen-
esis,50 human fibroblasts were serum-starved to induce
cilium formation and co-stained for acetylated a-tubulin.
In control fibroblasts, TAPT1 localized at the ciliary basal
body (Figure 3B upper panel, Figures S4 and S5). In
contrast, in cells from fetus II-3 from family 1, the primary
cilium was nearly absent and aberrant acetylated a-tubulin
was present throughout the cell (Figure 3B middle panel,
Figures S4 middle panel and S5), whereas for fetus IV-4
from family 2, the primary cilia formation was disturbed,
and TAPT1 was scattered throughout the cytoplasm
(Figure 3B lower panel, Figures S4 lower panel and S6).
Transfection of TAPT1 expression constructs into
HEK293T cells showed that wild-type TAPT1 localized to
the ciliary basal body, whereas both defective TAPT1 pro-
teins were spread throughout the cytoplasm (Figure S7).
Additionally, TAPT1-siRNA-treated MG-63 cells displayed
fewer and shorter primary cilia (Figure S8), and TAPT1-
shRNA-treated MG-63 cells revealed that centrosomes var-
ied more in size (Figure S9).
TAPT1 Defects Alter Collagen Folding and Secretion
Because both families were initially diagnosed with lethal
OI, several parameters of type I collagen biosynthesis were
evaluated. Biochemical analysis revealed that type I
collagen folding was moderately but significantly slower
in proband cells (Figure 4A), allowing longer exposure to
post-translational modifying enzymes. As a result, hydrox-
ylysine (Hyl) content of collagen synthesizedbyTAPT1pro-The Americband cells was increased (Hyl/total lysine content: control,
22.1% versus fetus IV-4, 39.0%) and the collagen a-chains
were moderately broadened and migrated more slowly on
gel electrophoresis (Figure 4B). In addition, the secretion
of type I collagen from the cells was slower (Figure 4C),
albeit the collagen stability was not altered (Figure S10).
TAPT1 Defects Alter Golgi Morphology and Trafficking
To investigate the mechanism by which TAPT1 defects
contributed to the observed collagen abnormalities,
we used CTx-B to examine the Golgi morphology
(Figure 5A) and plasma-membrane-to-Golgi protein traf-
ficking, (Figure 5B), a trafficking system that depends on
centrosome-derived microtubules.37 Whereas control cells
showed normal perinuclear, stacked Golgi morphology,
TAPT1 mutant cells had a more disperse, not-polarized,
and distended Golgi morphology (Figure 5A). Also, the
CTx-B experiment revealed altered trafficking of CTx-B
from the plasma membrane to the Golgi apparatus in
TAPT1mutant cells, which was most obvious for fetus II-3
from family 1 in comparison to fetus IV-4 from family 2
(Figure 5B, Table S2). The disturbed trafficking in proband
cells most likely accounts for the slower collagen folding
and overmodification (Figures 4A and 4B), as well as a
slightly delayed collagen secretion (Figure 4C).
Zebrafish Studies
The function of TAPT1 was further examined by studies in
zebrafish, which harbor two orthologs, tapt1a and tapt1b.an Journal of Human Genetics 97, 521–534, October 1, 2015 527
Figure 4. Type I Collagen Studies
(A) Intracellular collagen folding in proband fibroblasts is moderately delayed. n ¼ 3 for each cell line. * ¼ p < 0.05.
(B) Compared to controls, collagen biochemistry of proband fibroblasts showed broadened bands and delayed migration of the a1(I)-
and a2(I)-collagen chains.
(C) Collagen secretion assay. Left panel shows SDS-PAGE analysis of the intracellular and secreted fibrillar types I and V collagen during a
180min time range (timepoints are indicatedabove thegel). Rightpanel showsmeasurementof the intensities of the type I collagenbands
(ImageJ). This revealed that type I collagen is more slowly secreted from the proband fibroblasts. n ¼ 2–3 for each cell line. *p < 0.05.Because tapt1b is most homologous to human TAPT1, we
focused on this ortholog. WISH for tapt1b in embryos at
3 dpf showed strong expression in the mesenchyme of528 The American Journal of Human Genetics 97, 521–534, Octoberthe pectoral fins and the epithelial lining of the oropharyn-
geal cavity and weaker expression in the pronephric duct
and the liver (Figure S11). Ciliogenesis was investigatedFigure 5. Golgi Morphology and Traf-
ficking
(A) Dermal fibroblasts were stained for the
cilium (acetylated a-tubulin) and the Golgi
apparatus (Golph4). Whereas control cells
showed normal, perinuclear, stacked Golgi
morphology, fetal dermal fibroblasts (fetus
II-3 from family 1) showed altered and ve-
sicular Golgi morphology. Scale bars repre-
sent 50 mm.
(B) Dermal fibroblasts were labeled with
cholera toxin subunit B (CTx-B, green)
and stained for Golgi (red). Control cells
with normal Golgi morphology showed
internalization of CTx-B as visualized by
intense overlap of the Golgi apparatus
with CTx-B. Cells from fetus II-3 from fam-
ily 1 and fetus IV-4 from family 2 with a
more disperse and distended Golgi (white
arrows) showed less intense Golgi overlap
and some CTx-B mislocalization (yellow
arrows).
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Figure 6. tapt1b Knockdown in Zebrafish
(A) Cilia in zebrafish otic vesicle at 1 dpf, visualized by WISH, re-
vealed decreased cilial length in tapt1b morphants.
(B) Quantification of cilial length in three tapt1b morphants and
three uninjected controls. On average, cilia were 24% smaller in
the tapt1bmorphant group when compared to those in the unin-
jected group (p < 0.001). Measurements in the graph represent
relative cilial length in percentage when compared to the mean
cilial length of the uninjected group (100%). Each dot in the graph
represents a single measurement; dots with the same color shade
represent measurements for the same sample.in the otic vesicle, which shows high tapt1b expression at
1 dpf and which is easily accessible for confocal imaging.
In embryos in which tapt1b was depleted, via either of
two independent splice-blocking MOs, the cilia in the
otic vesicle showed decreased length, supporting a ciliary
function for tapt1b and TAPT1 (Figures 6A and 6B).
Tapt1b-depleted embryos (Figures 7A and 7B, Figures
S12A and S12B) further resulted in severe craniofacial dis-
tortions (Figure 7C, Figure S12C), microcephaly, malfor-
mation of the pectoral fins (evolutionarily related to
limbs), pericardial edema, and generally delayed ossifica-
tion (Figure 7D, Figure S12D), both in a wild-type and
p53 mutant44 background. Alcian blue staining for carti-
lage revealed a complete absence of ceratobranchial carti-
lages in tapt1bmorphant embryos and an abnormal polar-
ity of the ceratohyal cartilage (Figure 7C, Figure S12C). To
further confirm the specificity of our MO assay, we utilized
CRISPR/Cas9-mediated gene editing to induce aberrationsThe Americin tapt1b.51,52 In F0 tapt1bCas9/gRNA embryos, we observed
malformation of the cranial cartilage and disorganization
of chondrocytes in the ceratohyal and ceratobranchial
cartilage (Figure S13). These zebrafish MO tapt1b knock-
down and CRISPR/Cas9-induced tapt1b knock-out pheno-
types are concordant with the phenotypic abnormalities in
the affected fetuses in both families.
The defects in the morphant zebrafish craniofacial carti-
lage, which is predominantly derived from the CNC, were
analyzed in more detail. Histological staining showed
abnormal morphologies of cells in the oral epithelium
and the neighboring CNC-derived mesenchyme of tapt1b
morphants (Figure 7E, Figure S14). Whereas cartilage con-
densations were clearly visible in the pharyngeal arches of
control embryos, only undifferentiated loosely organized
mesenchymal cells were observed in tapt1b morphants
(Figure 7E), thereby suggesting that the defect is down-
stream of CNC cell migration. In line with this, tapt1b
depletion in fli1:GFP transgenic embryos, expressing GFP
in the CNC,39 also indicated the presence of post-migra-
tory CNC cells in the pharyngeal arches (Figure 7F). How-
ever, the presence of differentiated chondrocytes could
not be detected in the pharyngeal arches after tapt1b
depletion in col2a1:mCherry transgenic embryos, express-
ing mCherry under the control of the promotor of
col2a1,38 which is a marker gene for differentiated chon-
drocytes (Figure 7G).
Next, we performed WISH for barx1, a gene regulating
proliferation and differentiation of post-migratory
CNC,41 and sox9a, a transcription factor essential for chon-
drocyte differentiation.42 Expression of both markers was
unaffected in the precursors of the Meckel’s and ceratohyal
cartilage but was lost in the more posterior ceratobranchial
region (Figure 8). Together, our findings indicate that the
cartilage defect in the tapt1b morphants derived primarily
from disturbed condensation or differentiation of the CNC
cells after their migration into the branchial arches.Discussion
With our study, we established that genetic defects in
TAPT1 are the underlying cause of a lethal and complex
congenital disorder that is primarily characterized by severe
undermineralization of the skeleton with intra-uterine
fractures and that thus clinically overlaps with the presen-
tation of severe-to-lethal OI.3 However, additional pheno-
typicmanifestations, includingmicrocephaly, hydramnios
with ascites, intracranial ventriculomegaly, hydronephro-
sis, and other anomalies classify this disorder within the
complex developmental skeletal dysplasias. Additionally,
the observed dysfunction of the primary cilium may also
link this disorder to the ciliopathies. Some variation in dis-
ease severity in our families was observed; the observed
phenotypic congenital abnormalities were more severe in
family 2. This might be correlated with the ultimate effect
of TAPT1 mutations on primary cilium formation, in thatan Journal of Human Genetics 97, 521–534, October 1, 2015 529
Figure 7. Phenotypic Characterization of tapt1b Morphants
(A–B) Phenotype of the tapt1b morphants at 4 dpf. Shows cranio-
facial distortions, underdevelopment of the splanchnocranium,
microcephaly, malformation of the pectoral fins, and pericardial
edema.
(C) Alcian blue staining for cartilage at 4 dpf. tapt1bmorphant em-
bryos lacked ceratobranchial cartilages (cb) and showed abnormal
530 The American Journal of Human Genetics 97, 521–534, Octobercells from fetuses of family 1 almost failed to induce cilio-
genesis, whereas cells from fetuses of family 2 produced a
short and stubby cilium.
Although classic ciliopathies are known as multisyste-
mic disorders, ciliary chondrodyplasias have been
described that represent a group of genetically and pheno-
typically related disorders in which mainly the ribs, limbs,
and craniofacial skeleton are affected, but also sometimes
involve extraskeletal symptoms affecting the kidneys,
liver, heart, eyes, and other organs and tissues.53 The
underlying pathogenetic basis is found within malfunc-
tioning cilia, causing imbalances in the ciliary hedgehog
signaling pathway in chondrocytes. In 2010 and
2012,37,54–56 two additional ciliary chondrodysplasias
were described; both are characterized by primordial
dwarfism with microcephaly, and/or skeletal defects, and
are caused by defects in the centrosomal protein CENPJ
(encoding centromeric protein J)54,56 or the centrosome-
associated protein POC1A (encoding POC1 centriolar pro-
tein A).37,55 These proteins are among several centrosomal
components known to play a crucial role in the growth of
the primary cilium50 while also affecting intracellular
transport.57 In particular, POC1A is important for proper
assembly of the Golgi stacks and normal trafficking
through the Golgi apparatus,37 a finding that also seems
to hold true for TAPT1, as illustrated by disturbed Golgi
morphology and trafficking and alterations of type I
collagen biosynthesis. Also, it is possible that the altered
acetylated a-tubulin organization in the proband cells in-
fluences the pericentrosomal Golgi ribbon,58 thereby
contributing to the observed altered trafficking as illus-
trated by the CTx-B experiment. In analogy to the
observed disturbances of type I collagen in our families, a
recent study of a transgenic mouse model, allowing the
conditional expression of fluorescently labeled wild-type
or mutant (R992C) type II collagen, demonstrated a dis-
torted polarity of the Golgi apparatus to the nucleus axis
in mutant chondrocytes of the growth plate in combina-
tion with altered biosynthesis and secretion of mutant
type II collagen.59 Interestingly, in these transgenicpolarity of the ceratohyal cartilage (ch), whereas the palatoqua-
drate (pq) and Meckel’s cartilage (m) were largely unaffected.
(D) Alizarin red staining for bone at 4 dpf. tapt1b morphants
showed delayed ossification of the cranial skeleton.
(E) Histological examination of the pharyngeal region in the 3 dpf
tapt1b morphants showed abnormal cellular morphology in the
oral epithelium and the neighboring ectomesenchyme. In control
embryos (3 dpf), cartilage condensations were clearly visible in the
pharyngeal arches, whereas undifferentiated and misorganized
mesenchymal cells were present in tapt1bmorphants (Figure S12).
(F) tapt1b morphants in a fli1:GFP background revealed normal
migration of cranial neural crest cells, although they are less abun-
dant and more disorganized when compared to control embryos.
(G) tapt1b morphants in a col2a1:mCherry background display an
absence of differentiated chondrocytes in the pharyngeal arch re-
gion (cb). cb3, ceratobranchial 3; cb5, ceratobranchial 5; cl, cleith-
rum; ps, parasphenoid; nc, notochord; op, opercle; oc, oral cavity.
Scale bars represent 1 mm in (A), 200 mm in (B), (E), and (G) and
100 mm in (C), (D) and (F).
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Figure 8. WISH for sox9a and barx1
(A–B) Expression pattern of barx1, a gene regulating proliferation
and differentiation of post-migratory CNC,41 at 60 hpf (A) and
72 hpf (B) showed clear expression of barx1 in the region of the
pharyngeal arches in the uninjected controls (upper panel),
whereas no expression of barx1 in that region (arrowhead) was
detected in the tapt1b morphants (lower panel).
(C–D) Expression pattern of sox9a, a transcription factor essential
for chondrocyte differentiation,42 at 60 hpf (C) and 72 hpf (D)
showed normal expression of sox9a in the pharyngeal arch region
in the uninjected controls (upper panel), whereas no expression of
sox9a in the pharyngeal arch region (arrowhead) was detected in
the tapt1b morphants. Expression of both barx1 and sox9a was
not affected in the Meckel’s and ceratohyal cartilage. Scale bars
represent 200 mm.mutant chondrocytes, changes were also observed in
length and spatial orientation of the primary cilia. Hence,
it is was proposed that altered polarity of the chondrocytes
(expressing the mutant type II collagen) contributes to al-
terations in primary cilium organization, which in turn
can influence secretion and deposition of structural ele-The Americments, such as collagens, in the extracellular matrix.59,60
This overlap between Golgi and cilium alterations fits
well with the group of complex skeletal dysplasias, some
of which are associated with defects in primary-cilia ele-
ments and some with defects in the structural proteins of
the Golgi apparatus.61–63 In line with this, defective carti-
lage development might also underlie the bone fragility
in these families, resulting in the observed chondroosseous
dysplasia. Our findings in the tapt1b morphant zebrafish
revealed delayed ossification of cranial bones and aberrant
differentiation of the ceratobranchial cartilage precursors,
thus perturbing subsequent peri- and endochondral bone
formation. This implies that both dermal and chondral
bone development are distorted. This is supported by a
recent study that reported on the crucial role of the pri-
mary cilium to direct differentiation of mesenchymal
stem cells to chondrocytes and osteoblasts.64 One of the
best described pathways impacted by the primary cilium
is the Hedgehog (Hh) pathway, which is also centrally
involved in osteoblast commitment and differentia-
tion.65 Interestingly, the craniofacial phenotype of the
tapt1bmorphants is very similar to that of the con/disp1 ze-
brafish mutant, a hypomorphic disp1 zebrafish model that
was developed to characterize the role of Hh signaling in
the pharyngeal arches skeleton.66 Although the pheno-
typic overlap between both zebrafish models suggests a
direct involvement of the Hh-pathway in the tapt1b mor-
phant phenotype, alternative mechanisms cannot be
excluded given that primary cilia are also important for
alternative signaling pathways (e.g., Wnt or PDGF) and
also display mechanosensory functions, all of which can
be critical for cartilage and bone formation.1
In conclusion, TAPT1 is an, until now, uncharacterized
centrosome and/or ciliary basal body protein that could
have a dual role in cartilage and bone development. First,
as a centrosomal protein, TAPT1 affects intracellular pro-
tein trafficking and organization of cellular organelles,
such as the Golgi apparatus. Second, because TAPT1 could
play a role in ciliary assembly and signaling, it might affect
osteogenesis by influencing osteoblast and/or chondrocyte
differentiation. These insights contribute to the ongoing
unravelling of the pathways and proteins involved in
bone formation.Supplemental Data
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